Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, that’s it, nothing to see here, move on
A week has gone by without any news from MVNT and so my biggest problem with these guys is their CREDIBILITY. There's none left. Reminder: in 2 weeks the next quarterly is due.
The press release we are waiting for wasn’t drafted a week ago. No, it was announced in a tweet on 01/05/2023 or 4 months ago. Do these guys suck? Yes they do, big time!!!
Yes, they changed the time line to days......but a week has already gone by.....
well, maybe we don’t get news today, Linh’s busy in the kitchen
that PR with exciting news SHOULD be issued TODAY, not tomorrow or even later
$HALB $0.01 OS 565M MC 5.8M
Is testing at Mississippi State University a nasal spray (patent pending) to treat PTSD, ALZHEIMER's, EPILEPSY
JACKSON CENTER, PA / ACCESSWIRE / May 2, 2023 / Halberd Corporation (OTC PINK:HALB) advances its pursuit toward pre-clinical testing of its patent-pending nasal spray. The nasal spray is designed to counteract the generation of excess inflammatory cytokines resulting from head trauma. The focus of this study by Halberd and Mississippi State University is to discover the effectiveness of the nasal spray against multiple antigens, linked to head trauma and various neurodegenerative conditions like PTSD, Alzheimer's Disease, early onset Alzheimer's Disease, and Epilepsy.
https://www.otcmarkets.com/stock/HALB/news/Halberd-HALB-Pursuing-a-Nasal-Spray-to-Counteract-the-Effects-of-Head-Trauma?id=398900
$HALB $0.01 OS 565M MC 5.8M
Is testing at Mississippi State University a nasal spray (patent pending) to treat PTSD, ALZHEIMER's, EPILEPSY
JACKSON CENTER, PA / ACCESSWIRE / May 2, 2023 / Halberd Corporation (OTC PINK:HALB) advances its pursuit toward pre-clinical testing of its patent-pending nasal spray. The nasal spray is designed to counteract the generation of excess inflammatory cytokines resulting from head trauma. The focus of this study by Halberd and Mississippi State University is to discover the effectiveness of the nasal spray against multiple antigens, linked to head trauma and various neurodegenerative conditions like PTSD, Alzheimer's Disease, early onset Alzheimer's Disease, and Epilepsy.
https://www.otcmarkets.com/stock/HALB/news/Halberd-HALB-Pursuing-a-Nasal-Spray-to-Counteract-the-Effects-of-Head-Trauma?id=398900
Up list to big boards? They even don't qualify for OTCQB that requires a minimum SP of .01 for at least 30days. Without solid news the SP will not jump. Let's hope they announce a merger, but I have my doubts
MVNT is Pink Current now. They have to file the next quarterly on May 15 but most likely they ask for a 5 day extension. After that Pink Limited again
The annual report 2022 was filed yesterday. Not much to be optimistic about. Revenue down, financial position bad, BUT former parent company Renova Health is funding all operations. Meanwhile INQR is building their new integrated platform. INQR needs more time, but Renova seems convinced they will make it in the future.
You mean the update they announced on Twitter January 5th?
___________________________________________
gemstone57
Re: don estaban post# 60910
Wednesday, April 12, 2023 2:21:51 PM
Post# 60911 of 60918
Hope they follow through with a Press Release
$HALB 0.011 MC 6M
Halberd started animal testing today at Mississippi State University today. Testing their patent-pending nasal spray to treat BRAIN TRAUMA.
https://www.accesswire.com/748456/Halberd-Begins-Preclinical-Testing-at-Mississippi-State-University-MSU
I posted this company several times on this board. Shares are incredible cheap. Buy some and see your wealth grow in the months to come. But always do your own DD
$HALB 0.011 MC 6M
Halberd started animal testing today at Mississippi State University today. Testing their patent-pending nasal spray to treat BRAIN TRAUMA.
https://www.accesswire.com/748456/Halberd-Begins-Preclinical-Testing-at-Mississippi-State-University-MSU
I posted this company several times on this board. Shares are incredible cheap. Buy some and see your wealth grow in the months to come. But always do your own DD
Well, that's a surprise! Revenue up and a profit. No subsequent events
On Twitter someone (TIGRESS) says he visited the MVNT location and says it doesn't look like an actual business with employees and equipment.
Is TIGRESS posting here on Ihub as well? If so, can you explain?
Jack Leal in PR from 03/09/2022:
"Mr. Leal, new Chief Financial Officer, affirmed, “I personally believe in our Company’s products, services and our CEO, Mr. Nguyen. My goal is to ensure that the Company and stakeholders are receiving timely and accurate financial information, which ensures the Company can move toward even greater growth opportunities."
Yes, you're a joker
$HALB 0.0145 MC 8.2M
And there's more news. $HALB will run to dollars, mark my words
Halberd and Mississippi State University (MSU) Sign Agreement to Conduct Pre-Clinical Model Tests of Nasal Spray to Block Negative Effects of Head Trauma
https://www.otcmarkets.com/stock/HALB/news/Halberd-and-Mississippi-State-University-MSU-Sign-Agreement-to-Conduct-Pre-Clinical-Model-Tests-of-Nasal-Spray-to-Block-?id=395016
$HALB 0.0145 MC 8.2M
Yesterday:
$HALB had a very successful meeting with the #CDC today. The CDC had a team of five doctors at the meeting who evaluated the HALB ability to eradicate antibiotic resistant infectious bacteria in less than 10 minutes. Details to follow in a subsequent PR early next week.
https://www.otcmarkets.com/stock/HALB/news/Halberd-Eradicates-All-Strains-of-Antibiotic-Resistant-E-Coli-Provided-by-the-CDC-at-Youngstown-State-University?id=393949
$HALB 0.0145
Today Halberd Corp meets with the CDC officials to present lab results
Last week all media were writing about an emerging FUNGAL threat spreading at an alarming rate in US healthcare facilities: CANDIDA AURIS
https://edition.cnn.com/2023/03/20/health/fungus-candida-auris-increase/index.html
A few weeks ago HALB announced they succeeded in eradicating CANDIDA AURIS (donated by the CDC) from blood in as little as 5 minutes, using their fully patented technology:
https://www.otcmarkets.com/stock/HALB/news/Halberd-Corporation-Announces-Breakthrough-in-Candida-auris-Treatment?id=389644
DISRUPTIVE TECHNOLOGY, huge potential
$HALB 0.0145
Today Halberd Corp meets with the CDC officials to present lab results
Last week all media were writing about an emerging FUNGAL threat spreading at an alarming rate in US healthcare facilities: CANDIDA AURIS
https://edition.cnn.com/2023/03/20/health/fungus-candida-auris-increase/index.html
A few weeks ago HALB announced they succeeded in eradicating CANDIDA AURIS (donated by the CDC) from blood in as little as 5 minutes, using their fully patented technology:
https://www.otcmarkets.com/stock/HALB/news/Halberd-Corporation-Announces-Breakthrough-in-Candida-auris-Treatment?id=389644
DISRUPTIVE TECHNOLOGY, huge potential
What am I missing? Yesterdays volume was okay, but represents only 5K
$HALB SP 0.0145 OS 565 Million MC 8 Million
BREAKTHROUGH IN HEALTHCARE
Last week all media were writing about an emerging FUNGAL threat spreading at an alarming rate in US healthcare facilities: CANDIDA AURIS
https://edition.cnn.com/2023/03/20/health/fungus-candida-auris-increase/index.html
A few weeks ago HALB announced they succeeded in eradicating CANDIDA AURIS (donated by the CDC) from blood in as little as 5 minutes, using their fully patented technology:
https://www.otcmarkets.com/stock/HALB/news/Halberd-Corporation-Announces-Breakthrough-in-Candida-auris-Treatment?id=389644
Next week, Wednesday March 29th Halberd Corp. and the Centers for Disease Control (CDC) meet to discuss their incredible BREAKTHROUGH
https://www.otcmarkets.com/stock/HALB/news/Halberd--Centers-for-Disease-Control-to-Meet-Regarding-Eradication-of-Antibiotic-Resistant-Pathogens?id=393103
HALBERD WILL EXPLODE NEXT WEEK, DISRUPTIVE TECHNOLOGY, NO DRUG, FOR POTENTIAL COMPARE TESLA
$HALB SP 0.0145 OS 565 Million MC 8 Million
BREAKTHROUGH IN HEALTHCARE
Last week all media were writing about an emerging FUNGAL threat spreading at an alarming rate in US healthcare facilities: CANDIDA AURIS
https://edition.cnn.com/2023/03/20/health/fungus-candida-auris-increase/index.html
A few weeks ago HALB announced they succeeded in eradicating CANDIDA AURIS (donated by the CDC) from blood in as little as 5 minutes, using their fully patented technology:
https://www.otcmarkets.com/stock/HALB/news/Halberd-Corporation-Announces-Breakthrough-in-Candida-auris-Treatment?id=389644
Next week, Wednesday March 29th Halberd Corp. and the Center for Disease Control (CDC) meet to discuss their incredible BREAKTHROUGH
https://www.otcmarkets.com/stock/HALB/news/Halberd--Centers-for-Disease-Control-to-Meet-Regarding-Eradication-of-Antibiotic-Resistant-Pathogens?id=393103
HALBERD WILL EXPLODE NEXT WEEK, DISRUPTIVE TECHNOLOGY, NO DRUG, FOR POTENTIAL COMPARE TESLA
You're assuming Velocity does well, but we really don't know much about them do we? They don't publish their fins and what we knew is very old information.
Yes, you two are the only ones left who believe in $MVNT management. On twitter 2 guys left, but they just sound like Gem (LOL)
$HALB SP 0.0164 O/S 516M MarketCap 8.4M
Halberd Corp is slowly moving up for 3 reasons:
1) HALB starts ANIMAL TESTING (patent-pending nasal spray to treat brain trauma) at Mississippi State University
2) HALB is cooperating with the CDC on eradicating drug-resistant bacteria/viruses/fungi from blood, using their US-patented technology (partners
Arizona State University and Youngstown State University)
3) HALB expects huge funding, from the CDC and DARPA to start clinical trials asap
More info:
https://www.otcmarkets.com/stock/HALB/news
$HALB SP 0.0164 O/S 516M MarketCap 8.4M
Halberd Corp is slowly moving up for 3 reasons:
1) HALB starts ANIMAL TESTING (patent-pending nasal spray to treat brain trauma) at Mississippi State University
2) HALB is cooperating with the CDC on eradicating drug-resistant bacteria/viruses/fungi from blood, using their US-patented technology (partners
Arizona State University and Youngstown State University)
3) HALB expects huge funding, from the CDC and DARPA to start clinical trials asap
More info:
https://www.otcmarkets.com/stock/HALB/news
INQR's predecessor VMCS was shit, never delivered on its promises. But INQR so far did everything right. Audited figures and an upgrade to SEC reporting after filing Form 10Q-12G. They keep us up to date with press releases. We'll know soon enough if they can sell their healthcare modules directly or with help from XCPCNL. Liquidity is not a problem as the former parent company supplies funding. Watch how they manage their business, compare it to shitty MVNT. See the difference?
$INQR Our new platforms will feature intelligent applications using the latest AI and blockchain standards to provide high level automation for increased efficiency. Some $20 M have been invested to create a number of fully developed products and services which we offers through wholly-owned subsidiaries that provide medical support services primarily to clinical laboratories, corporate operations, rural hospitals, physician practices and behavioral health/substance abuse centers.
$INQR Is a fully SEC-reporting company and produces audited figures. Great future!
WEST PALM BEACH, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced the successful onboarding of a new multi-location facility to its Medical Mime EHR (Electronic Health Records) solution.
InnovaQor is pleased to confirm that its subsidiary Medical Mime, Inc. has onboarded a new Montana-based behavioral health client whose three locations will transition from an existing EHR to its Medical Mime solution over a three-month period. All Medical Mime clients pay an implementation fee to facilitate the installation of our EHR and training of staff, and then pay a monthly subscription fee based on the number of users.
WEST PALM BEACH, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR), Completes Agreement for Brand, Services and Product Marketing
InnovaQor has on February 24 signed an agreement with XCPCNL Business Services Corporation (OTC XCPL) to initiate a sales and marketing strategy for InnovaQor’s healthcare software products and services. XCPCNL will develop a Strategic Sales and Marketing program to meaningfully connect with targeted customers to cultivate the long-term growth and sustainability of the InnovaQor portfolio of services and products.
WEST PALM BEACH, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR), Subsidiary Launches Automated Billing Solution for customers
InnovaQor subsidiary, Medical Mime, Inc.,?a provider of an EHR (Electronic Health Records) software to behavioral health and substance abuse facilities, today announced the launch of an automated billing solution for use with its EHR software.
Expect a lot of news this month
$HALB still experimenting on 30 strains of antibiotic resistant bacteria donated by the CDC; especially the results killing Candida Auris (deadly) and Shigella (CDC sounded the alarm last week) very interesting and might lead to partnership with CDC and funding
Animal testing (nasal spray to treat brain trauma) starts at Mississippi State University, PR upcoming
No dilution since 08/16/2021
Hi, I always try to be a nice guy, so if you felt attacked by me I'm sorry.
Downgraded to Pink Limited again. You should stop spreading nonsense